R/R Multiple Myeloma: T-cell Redirection Therapy Shows Promise
A recent study has discovered the depth of biospheric antibodies. These are not responsible for deciding the way in which the patients will react in multiple myeloma to CAR T-cell. It is the second phase of the research project that has been published in the essential journal of blood advances. As a part of this…